PPT-Management of Autoimmune Liver Disease During COVID-19
Author : udeline | Published Date : 2024-01-03
Kelly W Burak MD FRCPC MSc Epid Professor Departments of Medicine amp Oncology University of Calgary Calgary AB Canada LIVER COMORBIDITIES AND COVID19 Autoimmune
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Management of Autoimmune Liver Disease D..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Management of Autoimmune Liver Disease During COVID-19: Transcript
Kelly W Burak MD FRCPC MSc Epid Professor Departments of Medicine amp Oncology University of Calgary Calgary AB Canada LIVER COMORBIDITIES AND COVID19 Autoimmune Hepatitis Diagnosis during pandemic. Chronic Liver Disease. Dr Ben Robinson F2. Plan for session. Introduction. Functions of liver. Causes of chronic liver disease. Symptoms and signs of chronic liver disease. Case based discussion. Complications of liver disease. and Understandable II – . Patterns of Inflammation. Dr Ian Chandler. February 2013. With acknowledgements to Prof S . Hubscher. , Birmingham. Patterns of Inflammation in the Liver. Portal inflammation. the Month:. Pediatric Diagnosis of IBD. Developed by the CCFA Nursing Initiatives Committee. Author: Kristin Madden, NP. University . of Nebraska Medical Center. Children’s Hospital & Medical Center. . LAYOUT. Definition. Epidemiology. Etiological classification. Clinical presentation. Approach to a child with CLD . Management. Upcoming research. . Chronic Liver Disease. . . Presence of ongoing injury within the liver. Navy . ACP 2014. Medication . DILI-. emma. : . The Masquerade . of Drug . Induced Liver . Injury. The views expressed in this presentation are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Army, Department of Defense, nor the U.S. Government. . Harpal S. Sandhu, MD, FRCSC. Retina Northwest. Clinical Professor. Casey Eye Institute. Department of Ophthalmology. Oregon Health and Science University. Adjunct Professor of Bioengineering. University of Louisville. Developed by the CCFA Nursing Initiatives Committee. Author: Kristin Madden, NP. University . of Nebraska Medical Center. Children’s Hospital & Medical Center. Instructions. To begin, please enter into “Presentation mode” to enable full interactivity of case and questions.. Dr. . Abdulwahhab. S. Abdullah. CABM, FICMS-G&H. Autoimmune hepatobiliary diseases. The liver is an important target for . immune-mediated . injury.. Three disease phenotypes are recognized:. autoimmune hepatitis (AIH). diseases are including autoimmune hepatitis and autoimmune sclerosis cholangitis Autoimmune Liver Disease A Guide What are autoimmune diseases? 4 What is autoimmune hepatitis (AIH)? 5 What is autoim ADVANCES IN HEPATOLOGYSection Editor: Eugene R. Schiff, MDCurrent Developments in the Treatment of Hepatitis and Hepatobiliary Disease What are the typical presenting How may the liver be involved? Mo News Briefing: . The Status of Autoimmune Disease. March 18, 2014. National Coalition of Autoimmune Patient Groups (NCAPG). 1. Agenda. Bob Goldberg. NCAPG, The National Coalition of Autoimmune Patient Groups. Gamal. . Esmat. (Egypt). Treatment considerations for COVID-19 in patients with chronic liver disease or after liver transplantation. Currently no drugs approved for CoVID-19, several tested, many under investigation.. Dec 2019. Liver cirrhosis. Objectives: . Define Cirrhosis.. Recognize the types of cirrhosis.. Recognize the causes and the pathogenic mechanisms leading to cirrhosis.. Describe the pathological findings in cirrhotic livers.. Menso. Westerouen van . Meeteren. and Joost PH . Drenth. . Radboud. UMC. , Nijmegen, The Netherlands . LIVER CO-MORBIDITIES AND COVID-19. Content. MAFLD and risk of . SARS-CoV-2. . transmission.
Download Document
Here is the link to download the presentation.
"Management of Autoimmune Liver Disease During COVID-19"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents